AE, M., BJ, R., S, L., S, M., KE, H., JL, W., . . . AS, D. G. (2025). Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products. Frontiers in immunology, 16, 1730346. https://doi.org/10.3389/fimmu.2025.1730346
Chicago Style (17th ed.) CitationAE, Mattei, et al. "Immunogenicity Risk Assessment of Peptide-related Impurities Identified in Generic Teriparatide Products." Frontiers in Immunology 16 (2025): 1730346. https://doi.org/10.3389/fimmu.2025.1730346.
MLA (9th ed.) CitationAE, Mattei, et al. "Immunogenicity Risk Assessment of Peptide-related Impurities Identified in Generic Teriparatide Products." Frontiers in Immunology, vol. 16, 2025, p. 1730346, https://doi.org/10.3389/fimmu.2025.1730346.
Warning: These citations may not always be 100% accurate.
